Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
Isordia
I
I
Carrasco
M
M
Chávez-Negrete
A
A
Palma-Aguirre
J A
JA
Flores-Murrieta
F J
FJ
Castañeda-Hernández
G
G
D001682:Biological Availability; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D002214:Capsules; D003692:Delayed-Action Preparations; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009200:Myocardial Contraction / Q000187:drug effects; D009543:Nifedipine / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors
D002121:Calcium Channel Blockers; D002214:Capsules; D003692:Delayed-Action Preparations; D009543:Nifedipine